BSVN Form 4: CEO Travis Thomas Sells 13,084 Shares; Retains 286,293

Rhea-AI Filing Summary

Travis Thomas L, President & CEO and director of Bank7 Corp. (BSVN), reported a sale of 13,084 shares of common stock on 08/26/2025 at a weighted-average price of $49.3566. After the sale, he beneficially owns 286,293 shares. The filing notes that the sale occurred in multiple transactions with prices ranging from $49.16 to $49.55. The reported holdings include several restricted stock unit (RSU) balances that vest on specified future dates, with detailed vesting schedules disclosed for multiple grants. No derivative transactions were reported.

Positive

• Reporting person retains a substantial stake of 286,293 shares after the sale, signaling ongoing alignment with shareholders
• Clear disclosure of weighted-average sale price and price range ($49.16 to $49.55) enhances transparency

Negative

• Insider sold 13,084 shares, a near-term reduction in the reporting person's direct holdings
• Multiple RSU grants vesting over time could result in future increases to share count attributable to the insider

Insights

Financial Analyst

TL;DR: Insider sale of 13,084 shares reduces CEO stake but he retains a substantial position (286,293 shares); sale prices ranged $49.16–$49.55.

The transaction is a routine disclosure of an insider sale rather than an equity issuance or option exercise. The weighted-average sale price of $49.3566 and the disclosed price range provide transparency on execution. The remaining beneficial ownership of 286,293 shares, including multiple RSU grants with staggered vesting dates, indicates continued alignment with shareholders while scheduling future compensation vesting. No options or derivative activity was reported, limiting complexity.

Corporate Governance Expert

TL;DR: A director/CEO executed open-market sales totaling 13,084 shares and remains a major insider holder with RSUs vesting over coming years.

The Form 4 documents an open-market disposition by the CEO and director, accompanied by clear footnote disclosure of a weighted-average price and the price range. The filing lists multiple RSU grants with explicit vesting schedules, which is important for assessing future insider dilution and retention incentives. The filing is procedural and compliant in form; it does not indicate unusual governance events such as accelerated vesting or transfers to affiliates.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Travis Thomas L

(Last) (First) (Middle)

1039 NW 63RD STREET

(Street)

OKLAHOMA CITY OK 73116

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Bank7 Corp. [ BSVN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & CEO

3. Date of Earliest Transaction (Month/Day/Year)
08/26/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock, par value $0.01 per share	08/26/2025		S		13,084	D	$49.3566(1)	286,293(2)(3)(4)(5)(6)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported is a weighted average. The shares were sold in multiple transactions at prices ranging from $49.16 to $49.55. Upon request, the reporting person will provide the SEC, the company, or any stockholder full information regarding the number of shares sold at each separate price in the range.

2. Includes 4,364 restricted stock units that vest in three equal installments on July 29, 2026, 2027, and 2028.

3. Includes 14,420 restricted stock units that vest in three equal installments on February 15, 2026, 2027, and 2028.

4. Includes 3,750 restricted stock units. The original grant of 15,000 restricted stock units vests in four equal installments on December 17, 2022, 2023, 2024, and 2025.

5. Includes 10,991 restricted stock units. The original grant of 16,486 restricted stock units vests in three equal installments on February 15, 2025, 2026, and 2027.

6. Includes 6,768 restricted stock units. The original grant of 20,302 restricted stock units vests in three equal installments on February 15, 2024, 2025, and 2026.

	John T. Phillips, Attorney-In-Fact	08/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Travis Thomas L do according to the Form 4 for BSVN?

He sold 13,084 shares of Bank7 Corp. common stock on 08/26/2025 at a weighted-average price of $49.3566.

How many shares does the reporting person own after the transaction?

The Form 4 reports beneficial ownership of 286,293 shares following the reported sale.

Were derivative securities reported on this Form 4 for BSVN?

No. Table II shows no derivative securities acquired, disposed of, or beneficially owned in this filing.

Does the filing disclose restricted stock units (RSUs)?

Yes. The filing discloses several RSU balances with vesting schedules, including grants that vest in installments in 2024–2028 as described in the footnotes.

What price range did the shares sell for in the reported transaction?

The shares were sold at prices ranging from $49.16 to $49.55, per the filing.